Product Name

  • Name

    Cephaloridine

  • EINECS
  • CAS No. 50-59-9
  • Article Data5
  • CAS DataBase
  • Density 1.3230 (rough estimate)
  • Solubility >20g/L(21 oC)
  • Melting Point 184°C
  • Formula C19H17 N3 O4 S2
  • Boiling Point
  • Molecular Weight 415.494
  • Flash Point
  • Transport Information
  • Appearance
  • Safety Experimental poison by intracerebral route. Moderately toxic to humans by intravenous route. Moderately toxic experimentally by ingestion, subcutaneous, intraperitoneal, and intravenous routes. Human systemic effects by intravenous route: nausea or vomiting and fatty liver degeneration. Experimental reproductive effects. When heated to decomposition it emits very toxic fumes of NOx and SOx.
  • Risk Codes 42/43
  • Molecular Structure Molecular Structure of 50-59-9 (Cephaloridine)
  • Hazard Symbols Xn
  • Synonyms Pyridinium,1-[[(6R,7R)-2-carboxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-,inner salt (9CI); Pyridinium,1-[[2-carboxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-,hydroxide, inner salt, (6R-trans)-; Pyridinium,1-[[2-carboxy-8-oxo-7-[2-(2-thienyl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-,hydroxide, inner salt (8CI); 7-[a-(2-Thienyl)acetamido]-3-(1-pyridylmethyl)-3-cephem-4-carboxylic acidbetaine; Aliporina; Ampligram; Cefaloridin; Cefaloridine; Ceflorin;Cepaloridin; Cepalorin; Ceph 87/4; Cephaloridin; Cephaloridine; Cephlodine;Ceporan; Ceporin; Ceporine; Cer; Cilifor; Deflorin; Faredina; Floridin;Glaxoridin; Intrasporin; Keflodin; Keflordin; Kefspor; Lilly 40602; Lloncefal;Loridine; Pyridinium,1-[[2-carboxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-,inner salt, (6R-trans)-; Sch 11527; Sefacin
  • PSA 146.96000
  • LogP 0.01100

Synthetic route

pyridine
110-86-1

pyridine

5-Methylene-2-[propylcarbamoyl-(2-thiophen-2-yl-acetylamino)-methyl]-5,6-dihydro-2H-[1,3]thiazine-4-carboxylic acid

5-Methylene-2-[propylcarbamoyl-(2-thiophen-2-yl-acetylamino)-methyl]-5,6-dihydro-2H-[1,3]thiazine-4-carboxylic acid

A

propylamine
107-10-8

propylamine

B

cefaloridine
50-59-9

cefaloridine

Conditions
ConditionsYield
With potassium chloride In water at 30℃; Equilibrium constant;
2,2,2-trichloroethyl (6R,7R)-N-<7-(thien-2-ylacetamido)ceph-3-em-3-ylmethyl>pyridinium chloride 4-carboxylate
85904-88-7

2,2,2-trichloroethyl (6R,7R)-N-<7-(thien-2-ylacetamido)ceph-3-em-3-ylmethyl>pyridinium chloride 4-carboxylate

cefaloridine
50-59-9

cefaloridine

Conditions
ConditionsYield
With Deacidite FF ion-exchange resin; zinc(II) chloride; zinc 1.) formic acid, 22 deg C, 2 h; Multistep reaction;
Δ2-cephaloridine

Δ2-cephaloridine

cefaloridine
50-59-9

cefaloridine

Conditions
ConditionsYield
With water-d2 at 37℃; Kinetics; Isomerization; pD = 10.5;
Cephaloridine epimer

Cephaloridine epimer

cefaloridine
50-59-9

cefaloridine

Conditions
ConditionsYield
With water-d2 at 37℃; Kinetics; Isomerization; pD = 10.5;
pyridine
110-86-1

pyridine

cefaloridine
50-59-9

cefaloridine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 67.3 percent / 1.5 h / 20 °C
2: 72.6 percent / phosphorus trichloride / CH2Cl2; dimethylformamide / 1.5 h / 21 °C
3: 1.) Zn, ZnCl2; 2.) Deacidite FF ion-exchange resin / 1.) formic acid, 22 deg C, 2 h
View Scheme
2-thienylacetic acid chloride
39098-97-0

2-thienylacetic acid chloride

cefaloridine
50-59-9

cefaloridine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.) phosphorus oxychloride; 2.) dimethylacetamide / 1.) MeOH, 45-55 deg C; 2.) CH2Cl2, 0-5 deg C, 45 min
2: 67.3 percent / 1.5 h / 20 °C
3: 72.6 percent / phosphorus trichloride / CH2Cl2; dimethylformamide / 1.5 h / 21 °C
4: 1.) Zn, ZnCl2; 2.) Deacidite FF ion-exchange resin / 1.) formic acid, 22 deg C, 2 h
View Scheme
Thiophene-2-acetic acid
1918-77-0

Thiophene-2-acetic acid

cefaloridine
50-59-9

cefaloridine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 46.3 percent / N,N'-dicyclohexylcarbodiimide / CH2Cl2 / 1 h / 20 °C
2: 67.3 percent / 1.5 h / 20 °C
3: 72.6 percent / phosphorus trichloride / CH2Cl2; dimethylformamide / 1.5 h / 21 °C
4: 1.) Zn, ZnCl2; 2.) Deacidite FF ion-exchange resin / 1.) formic acid, 22 deg C, 2 h
View Scheme
2,2,2-trichloroethyl (1S,6R,7R)-3-chloromethyl-7-(thien-2-ylacetamido)ceph-3-em-4-carboxylate 1-oxide
85904-87-6

2,2,2-trichloroethyl (1S,6R,7R)-3-chloromethyl-7-(thien-2-ylacetamido)ceph-3-em-4-carboxylate 1-oxide

cefaloridine
50-59-9

cefaloridine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 67.3 percent / 1.5 h / 20 °C
2: 72.6 percent / phosphorus trichloride / CH2Cl2; dimethylformamide / 1.5 h / 21 °C
3: 1.) Zn, ZnCl2; 2.) Deacidite FF ion-exchange resin / 1.) formic acid, 22 deg C, 2 h
View Scheme
2,2,2-trichloroethyl (1S,6R,7R)-N-<7-(thien-2-ylacetamido)ceph-3-em-3-ylmethyl>pyridinium chloride 4-carboxylate 1-oxide
33492-94-3

2,2,2-trichloroethyl (1S,6R,7R)-N-<7-(thien-2-ylacetamido)ceph-3-em-3-ylmethyl>pyridinium chloride 4-carboxylate 1-oxide

cefaloridine
50-59-9

cefaloridine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 72.6 percent / phosphorus trichloride / CH2Cl2; dimethylformamide / 1.5 h / 21 °C
2: 1.) Zn, ZnCl2; 2.) Deacidite FF ion-exchange resin / 1.) formic acid, 22 deg C, 2 h
View Scheme
2,2,2-trichloroethyl (1S,6R,7R)-7-amino-3-chloromethylceph-3-em-4-carboxylate 1-oxide
85904-84-3

2,2,2-trichloroethyl (1S,6R,7R)-7-amino-3-chloromethylceph-3-em-4-carboxylate 1-oxide

cefaloridine
50-59-9

cefaloridine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 46.3 percent / N,N'-dicyclohexylcarbodiimide / CH2Cl2 / 1 h / 20 °C
2: 67.3 percent / 1.5 h / 20 °C
3: 72.6 percent / phosphorus trichloride / CH2Cl2; dimethylformamide / 1.5 h / 21 °C
4: 1.) Zn, ZnCl2; 2.) Deacidite FF ion-exchange resin / 1.) formic acid, 22 deg C, 2 h
View Scheme
2,2,2-trichloroethyl (1S,6R,7R)-3-bromomethyl-7-formamidoceph-3-em-4-carboxylate 1-oxide
33465-56-4

2,2,2-trichloroethyl (1S,6R,7R)-3-bromomethyl-7-formamidoceph-3-em-4-carboxylate 1-oxide

cefaloridine
50-59-9

cefaloridine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.) phosphorus oxychloride; 2.) dimethylacetamide / 1.) MeOH, 45-55 deg C; 2.) CH2Cl2, 0-5 deg C, 45 min
2: 67.3 percent / 1.5 h / 20 °C
3: 72.6 percent / phosphorus trichloride / CH2Cl2; dimethylformamide / 1.5 h / 21 °C
4: 1.) Zn, ZnCl2; 2.) Deacidite FF ion-exchange resin / 1.) formic acid, 22 deg C, 2 h
View Scheme
Multi-step reaction with 5 steps
1: 46.2 percent / conc. hydrochloric acid / tetrahydrofuran / 30 h / 6 °C
2: 46.3 percent / N,N'-dicyclohexylcarbodiimide / CH2Cl2 / 1 h / 20 °C
3: 67.3 percent / 1.5 h / 20 °C
4: 72.6 percent / phosphorus trichloride / CH2Cl2; dimethylformamide / 1.5 h / 21 °C
5: 1.) Zn, ZnCl2; 2.) Deacidite FF ion-exchange resin / 1.) formic acid, 22 deg C, 2 h
View Scheme
cefaloridine
50-59-9

cefaloridine

(6R,7R)-N-<7-(thien-2-ylacetamido)ceph-3em-3-ylmethyl>-pyridinium-4-carboxylate hydronitrate

(6R,7R)-N-<7-(thien-2-ylacetamido)ceph-3em-3-ylmethyl>-pyridinium-4-carboxylate hydronitrate

Conditions
ConditionsYield
With nitric acid In water46.7%
dimethylacetylene
503-17-3

dimethylacetylene

cefaloridine
50-59-9

cefaloridine

A

but-1-yne
107-00-6

but-1-yne

B

2,3-dimethylbutene
590-19-2

2,3-dimethylbutene

Conditions
ConditionsYield
at 280℃;
Dimethylallene
598-25-4

Dimethylallene

cefaloridine
50-59-9

cefaloridine

A

3-methyl-but-1-yne
598-23-2

3-methyl-but-1-yne

B

isoprene
78-79-5

isoprene

Conditions
ConditionsYield
at 215 - 334℃;
tert-butylethylene
558-37-2

tert-butylethylene

cefaloridine
50-59-9

cefaloridine

2,3-Dimethyl-2-butene
563-79-1

2,3-Dimethyl-2-butene

Conditions
ConditionsYield
at 160 - 170℃;
(E)-4,4-dimethyl-2-pentene
690-08-4

(E)-4,4-dimethyl-2-pentene

cefaloridine
50-59-9

cefaloridine

2,3-dimethylpent-2-ene
10574-37-5

2,3-dimethylpent-2-ene

Conditions
ConditionsYield
at 150 - 270℃;
2,3-dimethylbutene
590-19-2

2,3-dimethylbutene

cefaloridine
50-59-9

cefaloridine

A

but-1-yne
107-00-6

but-1-yne

B

buta-1,3-diene
106-99-0

buta-1,3-diene

Conditions
ConditionsYield
at 330℃;
t-butylallene
26981-77-1

t-butylallene

cefaloridine
50-59-9

cefaloridine

2,4-dimethyl-2,3-pentadiene
1000-87-9

2,4-dimethyl-2,3-pentadiene

Conditions
ConditionsYield
at 230 - 235℃;
cefaloridine
50-59-9

cefaloridine

acetaldehyde
75-07-0

acetaldehyde

A

acetic acid
64-19-7

acetic acid

B

ethyl acetate
141-78-6

ethyl acetate

Conditions
ConditionsYield
at 250 - 400℃;
cefaloridine
50-59-9

cefaloridine

ethyl acetate
141-78-6

ethyl acetate

A

ethanol
64-17-5

ethanol

B

acetaldehyde
75-07-0

acetaldehyde

C

acetic acid
64-19-7

acetic acid

Conditions
ConditionsYield
at 300 - 400℃;
cefaloridine
50-59-9

cefaloridine

diphenyl hydrazine
122-66-7

diphenyl hydrazine

benzene
71-43-2

benzene

A

aniline
62-53-3

aniline

B

Azobenzene
1227476-15-4

Azobenzene

propylamine
107-10-8

propylamine

cefaloridine
50-59-9

cefaloridine

A

pyridine
110-86-1

pyridine

B

5-Methylene-2-[propylcarbamoyl-(2-thiophen-2-yl-acetylamino)-methyl]-5,6-dihydro-2H-[1,3]thiazine-4-carboxylic acid

5-Methylene-2-[propylcarbamoyl-(2-thiophen-2-yl-acetylamino)-methyl]-5,6-dihydro-2H-[1,3]thiazine-4-carboxylic acid

Conditions
ConditionsYield
With potassium chloride In water at 30℃; Rate constant; Equilibrium constant; effects of sodium hydroxide;
propylamine
107-10-8

propylamine

cefaloridine
50-59-9

cefaloridine

5-Methylene-2-[propylcarbamoyl-(2-thiophen-2-yl-acetylamino)-methyl]-5,6-dihydro-2H-[1,3]thiazine-4-carboxylic acid

5-Methylene-2-[propylcarbamoyl-(2-thiophen-2-yl-acetylamino)-methyl]-5,6-dihydro-2H-[1,3]thiazine-4-carboxylic acid

Conditions
ConditionsYield
With potassium chloride In water at 30℃;
hexafluoroacetone hydrate
677-71-4

hexafluoroacetone hydrate

cefaloridine
50-59-9

cefaloridine

A

C22H19F6N3O6S2

C22H19F6N3O6S2

B

C22H19F6N3O6S2

C22H19F6N3O6S2

Conditions
ConditionsYield
In water at 30℃; Rate constant; Mechanism; pH 5.5-12.5, I = 1.0 M (KCl);
2,2,2-trifluoroethanol
75-89-8

2,2,2-trifluoroethanol

cefaloridine
50-59-9

cefaloridine

A

C21H20F3N3O5S2

C21H20F3N3O5S2

B

C21H20F3N3O5S2

C21H20F3N3O5S2

Conditions
ConditionsYield
In water at 30℃; Rate constant; Mechanism; pH 10.5-13.5, I = 1.0 M (KCl);
1,1,1,3',3',3'-hexafluoro-propanol
920-66-1

1,1,1,3',3',3'-hexafluoro-propanol

cefaloridine
50-59-9

cefaloridine

A

C22H19F6N3O5S2

C22H19F6N3O5S2

B

C22H19F6N3O5S2

C22H19F6N3O5S2

Conditions
ConditionsYield
In water at 30℃; Rate constant; Mechanism; pH 8.35-12.5, I = 1.0 M (KCl);
cefaloridine
50-59-9

cefaloridine

A

pyridine
110-86-1

pyridine

B

(2R)-2-<(R)-carboxylato<(thien-2-yl)acetylamino>methyl>-5,6-dihydro-5-methylidene-1,3-thiazine-4-carboxylate
151338-10-2

(2R)-2-<(R)-carboxylato<(thien-2-yl)acetylamino>methyl>-5,6-dihydro-5-methylidene-1,3-thiazine-4-carboxylate

C

Δ2-cephaloridine

Δ2-cephaloridine

D

Cephaloridine epimer

Cephaloridine epimer

Conditions
ConditionsYield
at 37℃; for 1h; Product distribution; Rate constant; Mechanism; carbonate-buffer solution, pH 10.5;
With water-d2 at 37℃; Kinetics; Isomerization; hydrolysis; pD = 10.5;
cefaloridine
50-59-9

cefaloridine

C19H19N3O5S2

C19H19N3O5S2

Conditions
ConditionsYield
copper(II) ion In water at 30℃; Rate constant; Mechanism; further metal-ions, pH;
With hydrogenchloride In water at 30℃; Rate constant; hydrolysis;
With potassium chloride; 2-hydroxyethanethiol In water at 30℃; pH=10.10; Kinetics;
With potassium chloride; hydroxide In water at 30℃; Kinetics;
cefaloridine
50-59-9

cefaloridine

diamylene

diamylene

3-Methyl-1-butene
563-45-1

3-Methyl-1-butene

Conditions
ConditionsYield
at 150 - 160℃;
cefaloridine
50-59-9

cefaloridine

isobutene
115-11-7

isobutene

tetraisobutylene

tetraisobutylene

Conditions
ConditionsYield
Nachweis von 2,4,4,6,6,8,8-Heptamethyl-non-1-en in dem erhaltenen Produkt;
cefaloridine
50-59-9

cefaloridine

isobutene
115-11-7

isobutene

A

2,4,4-trimethyl-1-pentene
107-39-1

2,4,4-trimethyl-1-pentene

B

3-tert-Butyl-2,4,4-trimethyl-pent-2-ene
2437-52-7

3-tert-Butyl-2,4,4-trimethyl-pent-2-ene

C

tetraisobutylene

tetraisobutylene

D

pentaisobutylene

pentaisobutylene

Conditions
ConditionsYield
at 300℃; weitere Produkte: Hexaisobutylen, Heptaisobutylen;
cefaloridine
50-59-9

cefaloridine

diamylene

diamylene

2-methyl-but-2-ene
513-35-9

2-methyl-but-2-ene

Conditions
ConditionsYield
at 150 - 160℃;
1,1-Diphenylethylene
530-48-3

1,1-Diphenylethylene

cefaloridine
50-59-9

cefaloridine

A

1,1,3,3-tetraphenyl-1-butene
19244-53-2

1,1,3,3-tetraphenyl-1-butene

B

1.1.3.3-tetraphenyl-cyclobutane(?)

1.1.3.3-tetraphenyl-cyclobutane(?)

cefaloridine
50-59-9

cefaloridine

diamylene

diamylene

3-methyl-2-pentene
922-61-2

3-methyl-2-pentene

Conditions
ConditionsYield
at 150 - 160℃;

Cephaloridine Chemical Properties

Molecular Formula: C19H17N3O4S2
Molar mass: 415.486 g/mol
EINECS: 200-052-6
Structure of Cephaloridine (50-59-9):
    
XLogP3-AA: 1.9
H-Bond Donor: 1
H-Bond Acceptor: 4
Systematic Name: (6R,7R)-8-oxo-3-(Pyridin-1-ium-1-ylmethyl)-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 
SMILES: O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)Cc3sccc3)C[n+]4ccccc4)C([O-])=O 
InChI: InChI=1/C19H17N3O4S2/c23-14(9-13-5-4-8-27-13)20-15-17(24)22-16(19(25)26)12(11-28-18(15)22)10-21-6-2-1-3-7-21/h1-8,15,18H,9-11H2,(H-,20,23,25,26)/t15-,18-/m1/s1 
InChIKey: CZTQZXZIADLWOZ-CRAIPNDOBC 
Std. InChI: InChI=1S/C19H17N3O4S2/c23-14(9-13-5-4-8-27-13)20-15-17(24)22-16(19(25)26)12(11-28-18(15)22)10-21-6-2-1-3-7-21/h1-8,15,18H,9-11H2,(H-,20,23,25,26)/t15-,18-/m1/s1 
Std. InChIKey: CZTQZXZIADLWOZ-CRAIPNDOSA-N

Cephaloridine Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LD50 intramuscular > 200mg/kg (200mg/kg)   Toxicology and Applied Pharmacology. Vol. 8, Pg. 398, 1966.
dog LD intravenous > 1gm/kg (1000mg/kg) KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" Antimicrobial Agents and Chemotherapy Vol. -, Pg. 863, 1965.
dog LD50 subcutaneous > 200mg/kg (200mg/kg)   Toxicology and Applied Pharmacology. Vol. 8, Pg. 398, 1966.
guinea pig LD50 subcutaneous 550mg/kg (550mg/kg)   Toxicology and Applied Pharmacology. Vol. 8, Pg. 398, 1966.
man LDLo intravenous 1137mg/kg/4D (1137mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING
LIVER: FATTY LIVER DEGERATION
JAMA, Journal of the American Medical Association. Vol. 200, Pg. 724, 1967.
monkey LD50 intramuscular > 200mg/kg (200mg/kg)   Toxicology and Applied Pharmacology. Vol. 8, Pg. 398, 1966.
mouse LD50 intracrebral 10mg/kg (10mg/kg) BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"
MUSCULOSKELETAL: CHANGES IN TEETH AND SUPPORTING STRUCTURES
BEHAVIORAL: EXCITEMENT
Chemotherapy Vol. 26, Pg. 196, 1980.
 
mouse LD50 intramuscular 7gm/kg (7000mg/kg) KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" Byoin Yakugaku. Hospital Pharmacology. Vol. 3, Pg. 220, 1978.
mouse LD50 intraperitoneal 5355mg/kg (5355mg/kg) SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE
BEHAVIORAL: TREMOR
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Japanese Journal of Antibiotics. Vol. 29, Pg. 735, 1976.
mouse LD50 intravenous 2200mg/kg (2200mg/kg)   Toxicology and Applied Pharmacology. Vol. 8, Pg. 398, 1966.
mouse LD50 oral > 20gm/kg (20000mg/kg)   Japanese Journal of Antibiotics. Vol. 29, Pg. 735, 1976.
mouse LD50 subcutaneous 7745mg/kg (7745mg/kg)   Drugs in Japan Vol. -, Pg. 557, 1990.
rabbit LD50 intramuscular > 200mg/kg (200mg/kg)   Toxicology and Applied Pharmacology. Vol. 8, Pg. 398, 1966.
rat LD50 intraperitoneal 3170mg/kg (3170mg/kg)   Toxicology and Applied Pharmacology. Vol. 18, Pg. 185, 1971.
rat LD50 intravenous 1065mg/kg (1065mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
BEHAVIORAL: STRAUB TAIL
Japanese Journal of Antibiotics. Vol. 29, Pg. 735, 1976.
rat LD50 oral 2500mg/kg (2500mg/kg)   Toxicology and Applied Pharmacology. Vol. 8, Pg. 398, 1966.
rat LD50 parenteral 2500ug/kg (2.5mg/kg)   Antimicrobial Agents and Chemotherapy Vol. -, Pg. 863, 1965.
rat LD50 subcutaneous 2500mg/kg (2500mg/kg)   Toxicology and Applied Pharmacology. Vol. 8, Pg. 398, 1966.

Cephaloridine Safety Profile

Experimental poison by intracerebral route. Moderately toxic to humans by intravenous route. Moderately toxic experimentally by ingestion, subcutaneous, intraperitoneal, and intravenous routes. Human systemic effects by intravenous route: nausea or vomiting and fatty liver degeneration. Experimental reproductive effects. When heated to decomposition it emits very toxic fumes of NOx and SOx.

Cephaloridine Specification

 Cephaloridine (50-59-9) also can be called Cefaloridine ; N-[7-(2'-Thienylacetamidoceph-3-ylmethyl)]pyridinium-2-carboxylate ; (6R,7R)-8-Oxo-3-(1-pyridiniumylmethyl)-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate ; (6R-trans)-1-[[2-Carboxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]pyridinium Hydroxide Inner Salt ; Pyridinium, 1-[[(6R,7R)-2-carboxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-, inner salt ; and ; Cephaloridin .

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View